SXTC — CHINA SXT PHARMACEUTICALS IN
As of Q2 2026, 1 SEC-registered investment managers reported holding SXTC (CHINA SXT PHARMACEUTICALS IN) in their latest 13F filings, with a combined reported value of $2 across 1 shares. That is +0.0% by share count (+0 shares) versus the previous quarter, while reported value moved +0.0%. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.
SXTC is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Q2 2026 — 1 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| UBS Group AG history | 1 | $2 | 0.00% | Hold |
Q1 2026 — 1 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| UBS Group AG history | 1 | $2 | 0.00% | Reduce |
Q4 2025 — 4 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Citadel Advisors history | 150.58K | $240.92K | 0.00% | Add |
| Invesco Ltd history | 85.33K | $136.53K | 0.00% | Reduce |
| Geode Capital Management history | 53.67K | $85.87K | 0.00% | Hold |
| UBS Group AG history | 222 | $356 | 0.00% | Add |
Q3 2025 — 5 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Invesco Ltd history | 89.66K | $140.77K | 0.00% | New |
| Geode Capital Management history | 53.67K | $85.34K | 0.00% | New |
| Citadel Advisors history | 48.76K | $77.53K | 0.00% | New |
| Renaissance Technologies history | 44.50K | $69.86K | 0.00% | New |
| UBS Group AG history | 100 | $157 | 0.00% | Reduce |
Q2 2025 — 1 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| UBS Group AG history | 62.60K | $108.30K | 0.00% | Add |
Q1 2025 — 1 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| UBS Group AG history | 5.27K | $13.15K | 0.00% | Add |
New Positions (Q2 2026)
No fund opened a new position this quarter.
Fully Exited (vs previous quarter)
No tracked fund fully exited this quarter.
Fund Position History — shares by quarter (top 9 funds)
| Fund | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| UBS Group AG | 1 | 1 | 222 | 100 | 62.60K | 5.27K | 8 | 8.68K | 12.57K | 8 | 6.41K | 29.87K | — | 17.95K | 10.62K | 7.72K | — | 51.81K | 18.61K | — |
| Citadel Advisors | — | — | 150.58K | 48.76K | — | — | — | — | 16.11K | — | — | 191.34K | — | 24.41K | — | — | — | 266.28K | — | 10.75K |
| Renaissance Technologies | — | — | — | 44.50K | — | — | — | — | — | — | — | — | 10.54K | 34.50K | — | 21.57K | 29.47K | 451.50K | 21.40K | — |
| Geode Capital Management | — | — | 53.67K | 53.67K | — | — | — | — | — | — | — | — | — | — | — | — | — | 26.64K | 26.64K | 26.64K |
| Invesco Ltd | — | — | 85.33K | 89.66K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| JPMorgan Chase & Co | — | — | — | — | — | — | — | 376 | — | — | — | — | — | — | — | — | — | — | — | — |
| Bank of America Corp | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 4.08K | 1.13K |
| Citigroup Inc | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 34.20K | — | — |
| Millennium Management | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 67.65K | 45.69K | — | 12.39K | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details